Out-licensing

Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More

Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More

Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More

Enhancing the dissolution performance of small and large molecules in a range of dosage forms More

Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More

Diabetic retinopathy is one of the most common microvascular complications of diabetes, affecting nearly 50% of patients with diabetes. Diabetic retinopathy can affect almost anyone with diabetes, while an additional 5.4 million have undiagnosed dia More

EGT022 (human derived recombinant polypeptide) / Diabetic retinopathy, Retinopathy of prematurity More